Page last updated: 2024-08-21

berbamine and Osteosarcoma

berbamine has been researched along with Osteosarcoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Han, X; Hang, K; Hu, H; Li, J; Li, W; Li, Y; Tian, W; Xin, Z; Xu, R; Zhao, J1
Horne, DA; Jove, R; Liu, L; Nam, S; Tian, Y; Yang, F; Zhao, R1

Other Studies

2 other study(ies) available for berbamine and Osteosarcoma

ArticleYear
2-methylbenzoyl berbamine, a multi-targeted inhibitor, suppresses the growth of human osteosarcoma through disabling NF-κB, ERK and AKT signaling networks.
    Aging, 2020, 07-26, Volume: 12, Issue:14

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzylisoquinolines; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mice; Mice, Nude; NF-kappa B; Osteosarcoma; Proto-Oncogene Proteins c-akt

2020
A novel synthetic derivative of the natural product berbamine inhibits cell viability and induces apoptosis of human osteosarcoma cells, associated with activation of JNK/AP-1 signaling.
    Cancer biology & therapy, 2013, Volume: 14, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; Benzylisoquinolines; Bone Neoplasms; Caspase 3; Cell Line, Tumor; Cell Survival; Cyclin D1; Cyclin D2; Humans; JNK Mitogen-Activated Protein Kinases; Osteosarcoma; Phosphorylation; Reactive Oxygen Species; Signal Transduction; Transcription Factor AP-1

2013